D T M Nguyen1, N D Bang2, N Q Hung3, R P Beasley4, L-Y Hwang4, E A Graviss5. 1. Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, Texas, USA. 2. Pham Ngoc Thach Hospital for Tuberculosis and Lung Diseases, Ho Chi Minh City, Viet Nam. 3. Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam. 4. University of Texas School of Public Health, Texas, USA. 5. Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, Texas, USA; University of Texas School of Public Health, Texas, USA.
Abstract
SETTING: An Hoa Clinic, a district-level human immunodeficiency virus (HIV) clinic in Ho Chi Minh City, Viet Nam. OBJECTIVE: To assess the performance of chest radiograph (CXR) in screening for pulmonary tuberculosis (PTB) among HIV-infected individuals and identify misdiagnosed opportunities. DESIGN: This cross-sectional study was conducted in 397 HIV-infected patients consecutively enrolled at the An Hoa Clinic in Ho Chi Minh City, Viet Nam, from August 2009 to June 2010. The performance of CXR in TB screening was assessed based on its sensitivity, specificity, positive likelihood ratio and negative likelihood ratio. RESULTS: Symptom screening alone missed 50% of PTB cases. The combination of CXR and symptom screening yielded an additional 28.6% (8/28) in PTB screening as compared with symptom screening alone, and should be applied routinely, especially in high TB prevalent settings. CONCLUSION: CXR is a good predictor for PTB even in HIV-infected individuals. The combination of CXR and screening for common TB symptoms considerably improved the sensitivity of detecting active PTB in people living with HIV. If available, routine sputum culture and the World Health Organization-endorsed Xpert(®) MTB/RIF assay should be implemented to achieve a more accurate diagnosis.
SETTING: An Hoa Clinic, a district-level human immunodeficiency virus (HIV) clinic in Ho Chi Minh City, Viet Nam. OBJECTIVE: To assess the performance of chest radiograph (CXR) in screening for pulmonary tuberculosis (PTB) among HIV-infected individuals and identify misdiagnosed opportunities. DESIGN: This cross-sectional study was conducted in 397 HIV-infectedpatients consecutively enrolled at the An Hoa Clinic in Ho Chi Minh City, Viet Nam, from August 2009 to June 2010. The performance of CXR in TB screening was assessed based on its sensitivity, specificity, positive likelihood ratio and negative likelihood ratio. RESULTS: Symptom screening alone missed 50% of PTB cases. The combination of CXR and symptom screening yielded an additional 28.6% (8/28) in PTB screening as compared with symptom screening alone, and should be applied routinely, especially in high TB prevalent settings. CONCLUSION: CXR is a good predictor for PTB even in HIV-infected individuals. The combination of CXR and screening for common TB symptoms considerably improved the sensitivity of detecting active PTB in people living with HIV. If available, routine sputum culture and the World Health Organization-endorsed Xpert(®) MTB/RIF assay should be implemented to achieve a more accurate diagnosis.
Authors: Melissa S Sander; Sylvain N Laah; Collins N Titahong; Christian Lele; Thompson Kinge; Bouke C de Jong; Jean-Louis F Abena; Andrew J Codlin; Jacob Creswell Journal: J Clin Tuberc Other Mycobact Dis Date: 2019-02-18
Authors: Joanitah Nalunjogi; Frank Mugabe; Irene Najjingo; Pastan Lusiba; Francis Olweny; Joseph Mubiru; Edward Kayongo; Rogers Sekibira; Achilles Katamba; Bruce Kirenga Journal: Tuberc Res Treat Date: 2021-03-19
Authors: Ashar Dhana; Yohhei Hamada; Andre P Kengne; Andrew D Kerkhoff; Molebogeng X Rangaka; Tamara Kredo; Annabel Baddeley; Cecily Miller; Satvinder Singh; Yasmeen Hanifa; Alison D Grant; Katherine Fielding; Dissou Affolabi; Corinne S Merle; Ablo Prudence Wachinou; Christina Yoon; Adithya Cattamanchi; Christopher J Hoffmann; Neil Martinson; Eyongetah Tabenyang Mbu; Melissa S Sander; Taye T Balcha; Sten Skogmar; Byron W P Reeve; Grant Theron; Gcobisa Ndlangalavu; Surbhi Modi; Joseph Cavanaugh; Susan Swindells; Richard E Chaisson; Faiz Ahmad Khan; Andrea A Howard; Robin Wood; Swe Swe Thit; Mar Mar Kyi; Josh Hanson; Paul K Drain; Adrienne E Shapiro; Tendesayi Kufa; Gavin Churchyard; Duc T Nguyen; Edward A Graviss; Stephanie Bjerrum; Isik S Johansen; Jill K Gersh; David J Horne; Sylvia M LaCourse; Haider Abdulrazzaq Abed Al-Darraji; Adeeba Kamarulzaman; Russell R Kempker; Nestani Tukvadze; David A Barr; Graeme Meintjes; Gary Maartens Journal: Lancet Infect Dis Date: 2021-11-17 Impact factor: 71.421
Authors: Jose Cadena; Norys A Castro-Pena; Heta Javeri; Brian Hernandez; Joel Michalek; Ana Fuentes Arzola; Miloni Shroff; Chetan Jinadatha; Gustavo Valero; Jason Bowling; Jean Przykucki; Michele Adams; James Jorgensen; Jan E Patterson; Pranavi Sreeramoju Journal: Open Forum Infect Dis Date: 2017-09-16 Impact factor: 3.835
Authors: L H Chaisson; F Naufal; P Delgado-Barroso; H S Alvarez-Manzo; K O Robsky; C R Miller; J E Golub; A E Shapiro Journal: Int J Tuberc Lung Dis Date: 2021-06-01 Impact factor: 3.427